AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Novel Strategies for Reducing Burn Scar Itch

RecruitingPhase 3Ages 18 Years - 80 YearsAllThe University of Texas Medical Branch, Galveston
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Participants must meet all the inclusion criteria in order to be eligible to participate in the study. * Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures. * Adults: โ‰ฅ18 to \<80 years of age. * Has an itchy burn scar. Exclusion Criteria: Participants meeting any of the exclusion criteria at baseline will be excluded from study participation. * Failure to obtain consent or unable to return for follow up assessments. * Patient is unable to follow the protocol required assessments. * Member of a vulnerable class (e.g., prisoners, pregnant participant, etc.). * Any medical condition that, in the opinion of the investigator or physician, would place the participant at increased risk for participation. * Concurrent participation in another interventional clinical trial (to avoid confounding factors that may influence outcomes). * History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the participant to comply with the study procedures or follow the investigators instructions. * Age \< 18 or โ‰ฅ 80 years. * Taking one of the following medications: cefuroxime, dasatinib, delavirdine, neratinib, pazopanib, risedronate, or tizanidine. * Has a pre-existing inflammatory or itchy skin disease. * Is taking an H2 antihistamine for another indication.
๐Ÿ’Š

What it tests

  • Famotidine and 4% topical cromolyn sodium
  • Placebo
๐Ÿ“

Where

1 site
University of Texas Medical Branch, Galveston
Galveston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy